FutureFemHealth Pro
FutureFemHealth Pro is where our weekly briefing on innovation in women’s health goes deeper.
It’s built for the people shaping this space - founders, operators, investors, clinicians and partners.
Women’s health is progressing and expanding fast - and FutureFemHealth is here to make sense of that.
If you’re interested in a clearer view of where women’s health is actually going (beyond the headlines) then FutureFemHealth Pro might be for you.
What you get with Pro
🔍 Deeper analysis - not just news
Pro articles go beyond reporting to unpack what’s really happening underneath the surface.
That means:
Breaking down major deals and funding trends (what the numbers actually mean)
Identifying emerging categories before they’re labelled as such
Connecting dots across sectors - from digital health to pharma, AI to consumer tech
You’ll leave with a point of view, not just an update.
📊 Data, signals and original insight
Pro is increasingly where FutureFemHealth publishes its intelligence work.
This includes:
Quarterly funding analysis (including a downloadable funding tracker)
Deep dives and analysis on emerging categories - including market maps
Insights from operators and experts across the ecosystem
“Signals” - early indicators of where momentum is building
The goal: to help you see shifts earlier - and act on them.
🧠 Operator and insider perspectives
Alongside analysis, Pro features conversations and perspectives from the people building and backing the space.
Not surface-level interviews - but grounded insights into:
What’s actually working (and what isn’t)
How companies are positioning, scaling and navigating the market
Where the next opportunities - and risks - sit
How it fits with the weekly briefing
The free FutureFemHealth newsletter remains the weekly pulse of the space.
Pro is the layer beneath it:
Going deeper on the stories that matter most
Adding context, data and perspective
Publishing standalone analysis, reports and interviews
You can read the headlines without Pro.
But Pro is where you understand what they mean.
Recent Pro articles
Explore the latest Pro pieces below - including deep dives, signals and analysis:
Q1 funding: what $1.24b into women’s health really tells us
Welcome to the first FutureFemHealth Pro - a new paid layer where I’ll be sharing more analysis, insights and opinions on the future of women’s health and Femtech.
Why the bone health market is moving earlier
A woman in her early 60s slips, falls, and breaks her hip. Within a year, there’s a one in five chance she won’t survive.
Is Organon’s acquisition good for women’s health - or just good business?
When Organon was spun out of Merck & Co. in 2021, it stood out as one of the few scaled pharmaceutical companies built explicitly around women’s health.
Join FutureFemHealth Pro
If you want a clearer, more informed view of where women’s health is heading — Pro is where that thinking happens.
Join FutureFemHealth Pro to access:
In-depth analysis and deep dives
Data, reports and downloadable resources
Signals and emerging category insights
Full access to all Pro articles